{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-17T09:59:42.511569+00:00","published_at":"2026-10-17T04:45:14.05764+00:00","section":"evidence","data":{"state":"PUBLISHED","evidence":[{"evidence_id":"alpha:projection-evidence:bb1a4a424fa8202edd898231e1b29c0b0f9d1451c1dd90f65aab19d9158e4505","aliases":[],"source_type":"canonical_identity","source_family":"open_web","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/regeneron-pharmaceuticals-inc","title":"Alpha canonical company public projection","identifier":null,"locator":null,"source_date":null,"retrieved_at":"2026-10-17T04:45:14.05764+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"open_web","score":35,"source_family":"open_web","reasons":["Matched open_web source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:legal_name:1","stance":"supports"},{"claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:entity_status:3","stance":"supports"},{"claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:published_fact:5","stance":"supports"},{"claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:published_fact:6","stance":"supports"},{"claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:published_fact:7","stance":"supports"},{"claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:security_listing:44","stance":"supports"}],"claim_ids":["alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:legal_name:1","alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:entity_status:3","alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:published_fact:5","alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:published_fact:6","alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:published_fact:7","alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:security_listing:44"]},{"evidence_id":"alpha:projection-evidence:d5f9d8672c40ba80285d68faa0577c9aa742ef81c5842dd994b43587f2f9fabf","aliases":[],"source_type":"SEC filing","source_family":"sec","publisher":"REGENERON PHARMACEUTICALS, INC. Form 10-K (filed 2026-02-04)","url":"https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/regn-20251231.htm","title":"REGENERON PHARMACEUTICALS, INC. Form 10-K (filed 2026-02-04)","identifier":null,"locator":null,"source_date":null,"retrieved_at":"2026-08-29T22:22:03Z","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:official_website:4","stance":"supports"},{"claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:published_fact:8","stance":"supports"}],"claim_ids":["alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:official_website:4","alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:published_fact:8"]},{"evidence_id":"alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3","aliases":[],"source_type":"sec_proxy","source_family":"sec","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","title":"Regeneron Pharmaceuticals, Inc. DEF 14A 2026-04-24","identifier":null,"locator":null,"source_date":"2026-04-24","retrieved_at":"2026-04-24T20:10:05.384+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:9","stance":"supports"},{"claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:10","stance":"supports"},{"claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:11","stance":"supports"},{"claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:12","stance":"supports"},{"claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:13","stance":"supports"},{"claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:14","stance":"supports"},{"claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:15","stance":"supports"},{"claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:16","stance":"supports"},{"claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:17","stance":"supports"},{"claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:18","stance":"supports"},{"claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:19","stance":"supports"},{"claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:20","stance":"supports"},{"claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:21","stance":"supports"}],"claim_ids":["alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:9","alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:10","alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:11","alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:12","alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:13","alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:14","alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:15","alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:16","alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:17","alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:18","alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:19","alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:20","alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:21"]},{"evidence_id":"alpha:projection-evidence:document:bfaa15f5ba82da1d14fb28148e414ec5206e186b9707d93429af346776541043","aliases":[],"source_type":"sec_def_14a","source_family":"sec","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","title":"SEC DEF 14A 0001308179-26-000340","identifier":null,"locator":null,"source_date":"2026-04-24T00:00:00+00:00","retrieved_at":"2026-09-14T16:52:57.731588+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:22","stance":"supports"},{"claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:23","stance":"supports"},{"claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:24","stance":"supports"},{"claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:25","stance":"supports"},{"claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:27","stance":"supports"}],"claim_ids":["alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:22","alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:23","alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:24","alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:25","alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:27"]},{"evidence_id":"alpha:projection-evidence:document:d1265880b1e2ef08d82c9a445c87fe66862069e264638236b86548dd48aa0a99","aliases":[],"source_type":"sec_filing","source_family":"sec","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/regn-20251231.htm","title":"REGN 10-K executive officers","identifier":null,"locator":null,"source_date":"2026-02-04T00:00:00+00:00","retrieved_at":"2026-07-11T00:40:32.155611+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:26","stance":"supports"}],"claim_ids":["alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:26"]},{"evidence_id":"alpha:projection-evidence:158ef090c3ad2807947a27e846a1bcfe83a16821367e4fc9ca00a2e35137f4b8","aliases":[],"source_type":"sp500-board-director-completeness-remediation-2026-05-15","source_family":"sec","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","title":"Audit","identifier":null,"locator":null,"source_date":null,"retrieved_at":null,"content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_record:28","stance":"supports"},{"claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_appointment:29","stance":"supports"},{"claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_appointment:30","stance":"supports"},{"claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_record:31","stance":"supports"},{"claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_appointment:32","stance":"supports"},{"claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_appointment:33","stance":"supports"},{"claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_record:34","stance":"supports"},{"claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_appointment:35","stance":"supports"},{"claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_appointment:36","stance":"supports"},{"claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_appointment:37","stance":"supports"},{"claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_record:38","stance":"supports"},{"claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_appointment:39","stance":"supports"},{"claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_record:40","stance":"supports"},{"claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_appointment:41","stance":"supports"}],"claim_ids":["alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_record:28","alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_appointment:29","alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_appointment:30","alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_record:31","alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_appointment:32","alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_appointment:33","alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_record:34","alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_appointment:35","alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_appointment:36","alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_appointment:37","alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_record:38","alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_appointment:39","alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_record:40","alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_appointment:41"]},{"evidence_id":"alpha:projection-evidence:827a22a1567eda11fa866650563f33918ee2975144378fa7fd6f46399da5427a","aliases":[],"source_type":"index_provider","source_family":"open_web","publisher":"Slickcharts S&P 500 constituent table (public observation, not S&P DJI license)","url":"https://www.slickcharts.com/sp500","title":"S&P 500","identifier":null,"locator":null,"source_date":null,"retrieved_at":"2026-09-02T01:46:54.035948+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"open_web","score":35,"source_family":"open_web","reasons":["Matched open_web source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:index_membership:42","stance":"supports"}],"claim_ids":["alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:index_membership:42"]},{"evidence_id":"alpha:projection-evidence:24e3e0a1948ea10a66303a2e7032cc9bbc5c4edf5c6d4eb77b262a15ea2009a5","aliases":[],"source_type":"index_provider","source_family":"open_web","publisher":"Nasdaq official Nasdaq-100 list-type API","url":"https://api.nasdaq.com/api/quote/list-type/nasdaq100","title":"Nasdaq-100","identifier":null,"locator":null,"source_date":null,"retrieved_at":"2026-09-02T01:47:46.199772+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"open_web","score":35,"source_family":"open_web","reasons":["Matched open_web source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:index_membership:43","stance":"supports"}],"claim_ids":["alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:index_membership:43"]}]},"claims":[{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:legal_name:1","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"schema:legalName","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"REGENERON PHARMACEUTICALS, INC.","claim_type":"legal_name","predicate_id":"alpha:predicate:legal_name","predicate_version":1,"machine_key":"legal_name","human_label":"Legal Name","governed_predicate":true,"machine_value":"REGENERON PHARMACEUTICALS, INC.","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:bb1a4a424fa8202edd898231e1b29c0b0f9d1451c1dd90f65aab19d9158e4505","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/regeneron-pharmaceuticals-inc","source_date":null,"retrieved_at":"2026-10-17T04:45:14.05764+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:entity_status:3","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:entityStatus","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Public listing published","claim_type":"entity_status","predicate_id":"alpha:predicate:entity_status","predicate_version":1,"machine_key":"entity_status","human_label":"Entity Status","governed_predicate":true,"machine_value":"Public listing published","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:bb1a4a424fa8202edd898231e1b29c0b0f9d1451c1dd90f65aab19d9158e4505","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/regeneron-pharmaceuticals-inc","source_date":null,"retrieved_at":"2026-10-17T04:45:14.05764+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:official_website:4","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"schema:url","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"https://www.regeneron.com","claim_type":"official_website","predicate_id":"alpha:predicate:official_website","predicate_version":1,"machine_key":"official_website","human_label":"Official Website","governed_predicate":true,"machine_value":"https://www.regeneron.com","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:d5f9d8672c40ba80285d68faa0577c9aa742ef81c5842dd994b43587f2f9fabf","identity_scope":"representation_reference","source_type":"SEC filing","title":"REGENERON PHARMACEUTICALS, INC. Form 10-K (filed 2026-02-04)","publisher":"REGENERON PHARMACEUTICALS, INC. Form 10-K (filed 2026-02-04)","url":"https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/regn-20251231.htm","source_date":null,"retrieved_at":"2026-08-29T22:22:03Z","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:published_fact:5","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:country","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"US","claim_type":"published_fact","predicate_id":"alpha:predicate:published_fact","predicate_version":1,"machine_key":"published_fact","human_label":"Published Fact","governed_predicate":true,"machine_value":"US","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:bb1a4a424fa8202edd898231e1b29c0b0f9d1451c1dd90f65aab19d9158e4505","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/regeneron-pharmaceuticals-inc","source_date":null,"retrieved_at":"2026-10-17T04:45:14.05764+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:published_fact:6","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:jurisdiction","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"NY","claim_type":"published_fact","predicate_id":"alpha:predicate:published_fact","predicate_version":1,"machine_key":"published_fact","human_label":"Published Fact","governed_predicate":true,"machine_value":"NY","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:bb1a4a424fa8202edd898231e1b29c0b0f9d1451c1dd90f65aab19d9158e4505","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/regeneron-pharmaceuticals-inc","source_date":null,"retrieved_at":"2026-10-17T04:45:14.05764+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:published_fact:7","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:sector","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Healthcare","claim_type":"published_fact","predicate_id":"alpha:predicate:published_fact","predicate_version":1,"machine_key":"published_fact","human_label":"Published Fact","governed_predicate":true,"machine_value":"Healthcare","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:bb1a4a424fa8202edd898231e1b29c0b0f9d1451c1dd90f65aab19d9158e4505","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/regeneron-pharmaceuticals-inc","source_date":null,"retrieved_at":"2026-10-17T04:45:14.05764+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:published_fact:8","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:official_website","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"https://www.regeneron.com","claim_type":"published_fact","predicate_id":"alpha:predicate:published_fact","predicate_version":1,"machine_key":"published_fact","human_label":"Published Fact","governed_predicate":true,"machine_value":"https://www.regeneron.com","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:d5f9d8672c40ba80285d68faa0577c9aa742ef81c5842dd994b43587f2f9fabf","identity_scope":"representation_reference","source_type":"SEC filing","title":"REGENERON PHARMACEUTICALS, INC. Form 10-K (filed 2026-02-04)","publisher":"REGENERON PHARMACEUTICALS, INC. Form 10-K (filed 2026-02-04)","url":"https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/regn-20251231.htm","source_date":null,"retrieved_at":"2026-08-29T22:22:03Z","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:9","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:arthur-f-ryan","object_label":"Anita J. Ryan","object_source_name_forms":[],"value":"Anita J. Ryan: Independent Director, Audit; Corporate Governance and Compliance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:arthur-f-ryan","name":"Anita J. Ryan"},"title":"Independent Director","role_category":"director","committee":"Audit; Corporate Governance and Compliance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2003-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2003-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Regeneron Pharmaceuticals, Inc. DEF 14A 2026-04-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":"2026-04-24","retrieved_at":"2026-04-24T20:10:05.384+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":"2003-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:10","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:bonnie-l-bassler","object_label":"Bonnie L. Bassler","object_source_name_forms":[],"value":"Bonnie L. Bassler: Independent Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:bonnie-l-bassler","name":"Bonnie L. Bassler"},"title":"Independent Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2016-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2016-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Regeneron Pharmaceuticals, Inc. DEF 14A 2026-04-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":"2026-04-24","retrieved_at":"2026-04-24T20:10:05.384+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":"2016-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:11","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:christine-a-poon","object_label":"Christine A. Poon","object_source_name_forms":[],"value":"Christine A. Poon: Lead Independent Director, Compensation · Chair; Corporate Governance and Compliance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:christine-a-poon","name":"Christine A. Poon"},"title":"Lead Independent Director","role_category":"director","committee":"Compensation · Chair; Corporate Governance and Compliance","is_board_chair":false,"is_independent":true,"start_date":"2010-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2010-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Regeneron Pharmaceuticals, Inc. DEF 14A 2026-04-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":"2026-04-24","retrieved_at":"2026-04-24T20:10:05.384+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":"2010-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:12","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:craig-b-thompson","object_label":"Craig B. Thompson","object_source_name_forms":[],"value":"Craig B. Thompson: Director, Corporate Governance and Compliance; Digital Technology; Technology","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:craig-b-thompson","name":"Craig B. Thompson"},"title":"Director","role_category":"director","committee":"Corporate Governance and Compliance; Digital Technology; Technology","is_board_chair":false,"is_independent":true,"start_date":"2022-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2022-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Regeneron Pharmaceuticals, Inc. DEF 14A 2026-04-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":"2026-04-24","retrieved_at":"2026-04-24T20:10:05.384+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":"2022-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:13","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:david-p-schenkein","object_label":"David P. Schenkein","object_source_name_forms":[],"value":"David P. Schenkein: Independent Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:david-p-schenkein","name":"David P. Schenkein"},"title":"Independent Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Regeneron Pharmaceuticals, Inc. DEF 14A 2026-04-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":"2026-04-24","retrieved_at":"2026-04-24T20:10:05.384+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:14","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:george-d-yancopoulos","object_label":"George D. Yancopoulos","object_source_name_forms":[],"value":"George D. Yancopoulos: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:george-d-yancopoulos","name":"George D. Yancopoulos"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2001-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2001-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Regeneron Pharmaceuticals, Inc. DEF 14A 2026-04-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":"2026-04-24","retrieved_at":"2026-04-24T20:10:05.384+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":"2001-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:15","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:george-l-sing","object_label":"George L. Sing","object_source_name_forms":[],"value":"George L. Sing: Independent Director, Audit · Chair; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:george-l-sing","name":"George L. Sing"},"title":"Independent Director","role_category":"director","committee":"Audit · Chair; Compensation","is_board_chair":false,"is_independent":true,"start_date":"1988-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"1988-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Regeneron Pharmaceuticals, Inc. DEF 14A 2026-04-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":"2026-04-24","retrieved_at":"2026-04-24T20:10:05.384+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":"1988-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:16","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:huda-y-zoghbi","object_label":"Huda Y. Zoghbi","object_source_name_forms":[],"value":"Huda Y. Zoghbi: Independent Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:huda-y-zoghbi","name":"Huda Y. Zoghbi"},"title":"Independent Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2016-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2016-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Regeneron Pharmaceuticals, Inc. DEF 14A 2026-04-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":"2026-04-24","retrieved_at":"2026-04-24T20:10:05.384+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":"2016-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:17","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:joseph-l-goldstein","object_label":"Joseph L. Goldstein","object_source_name_forms":[],"value":"Joseph L. Goldstein: Independent Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:joseph-l-goldstein","name":"Joseph L. Goldstein"},"title":"Independent Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"1991-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"1991-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Regeneron Pharmaceuticals, Inc. DEF 14A 2026-04-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":"2026-04-24","retrieved_at":"2026-04-24T20:10:05.384+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":"1991-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:18","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:kathryn-guarini","object_label":"Kathryn Guarini","object_source_name_forms":[],"value":"Kathryn Guarini: Independent Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:kathryn-guarini","name":"Kathryn Guarini"},"title":"Independent Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Regeneron Pharmaceuticals, Inc. DEF 14A 2026-04-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":"2026-04-24","retrieved_at":"2026-04-24T20:10:05.384+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:19","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:leonard-s-schleifer","object_label":"Leonard S. Schleifer","object_source_name_forms":[],"value":"Leonard S. Schleifer: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:leonard-s-schleifer","name":"Leonard S. Schleifer"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"1988-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"1988-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Regeneron Pharmaceuticals, Inc. DEF 14A 2026-04-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":"2026-04-24","retrieved_at":"2026-04-24T20:10:05.384+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":"1988-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:20","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:michael-s-brown","object_label":"Michael S. Brown","object_source_name_forms":[],"value":"Michael S. Brown: Independent Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:michael-s-brown","name":"Michael S. Brown"},"title":"Independent Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"1991-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"1991-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Regeneron Pharmaceuticals, Inc. DEF 14A 2026-04-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":"2026-04-24","retrieved_at":"2026-04-24T20:10:05.384+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":"1991-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:21","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:n-anthony-coles","object_label":"N. Anthony Coles","object_source_name_forms":[],"value":"N. Anthony Coles: Independent Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:n-anthony-coles","name":"N. Anthony Coles"},"title":"Independent Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2017-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2017-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Regeneron Pharmaceuticals, Inc. DEF 14A 2026-04-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":"2026-04-24","retrieved_at":"2026-04-24T20:10:05.384+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":"2017-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:22","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:andrew-j-murphy-ph-d","object_label":"Andrew J. Murphy, Ph.D.","object_source_name_forms":[],"value":"Andrew J. Murphy, Ph.D.: Executive Vice President, Co-Chief Scientific Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:andrew-j-murphy-ph-d","name":"Andrew J. Murphy, Ph.D."},"title":"Executive Vice President, Co-Chief Scientific Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:document:bfaa15f5ba82da1d14fb28148e414ec5206e186b9707d93429af346776541043","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001308179-26-000340","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":"2026-04-24T00:00:00+00:00","retrieved_at":"2026-09-14T16:52:57.731588+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:23","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:christopher-fenimore","object_label":"Christopher Fenimore","object_source_name_forms":[],"value":"Christopher Fenimore: Executive Vice President, Finance and Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:christopher-fenimore","name":"Christopher Fenimore"},"title":"Executive Vice President, Finance and Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:document:bfaa15f5ba82da1d14fb28148e414ec5206e186b9707d93429af346776541043","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001308179-26-000340","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":"2026-04-24T00:00:00+00:00","retrieved_at":"2026-09-14T16:52:57.731588+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:24","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:daniel-p-van-plew","object_label":"Daniel P. Van Plew","object_source_name_forms":[],"value":"Daniel P. Van Plew: Executive Vice President and General Manager, Industrial Operations and Product Supply","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:daniel-p-van-plew","name":"Daniel P. Van Plew"},"title":"Executive Vice President and General Manager, Industrial Operations and Product Supply","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:document:bfaa15f5ba82da1d14fb28148e414ec5206e186b9707d93429af346776541043","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001308179-26-000340","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":"2026-04-24T00:00:00+00:00","retrieved_at":"2026-09-14T16:52:57.731588+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:25","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:george-d-yancopoulos-m-d-ph-d-regeneron-pharmaceuticals-inc","object_label":"George D. Yancopoulos, M.D., Ph.D.","object_source_name_forms":[],"value":"George D. Yancopoulos, M.D., Ph.D.: Board co-Chair, President and Chief Scientific Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:george-d-yancopoulos-m-d-ph-d-regeneron-pharmaceuticals-inc","name":"George D. Yancopoulos, M.D., Ph.D."},"title":"Board co-Chair, President and Chief Scientific Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:document:bfaa15f5ba82da1d14fb28148e414ec5206e186b9707d93429af346776541043","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001308179-26-000340","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":"2026-04-24T00:00:00+00:00","retrieved_at":"2026-09-14T16:52:57.731588+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:26","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:leonard-s-schleifer","object_label":"Leonard S. Schleifer","object_source_name_forms":[],"value":"Leonard S. Schleifer: Chief Executive Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:leonard-s-schleifer","name":"Leonard S. Schleifer"},"title":"Chief Executive Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-02-04","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-02-04","valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:document:d1265880b1e2ef08d82c9a445c87fe66862069e264638236b86548dd48aa0a99","identity_scope":"source_document_reference","source_type":"sec_filing","title":"REGN 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/regn-20251231.htm","source_date":"2026-02-04T00:00:00+00:00","retrieved_at":"2026-07-11T00:40:32.155611+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-02-04T00:00:00+00:00","effective_from":"2026-02-04","effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:27","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:leonard-s-schleifer-m-d-ph-d-regeneron-pharmaceuticals-inc","object_label":"Leonard S. Schleifer, M.D., Ph.D.","object_source_name_forms":[],"value":"Leonard S. Schleifer, M.D., Ph.D.: Board co-Chair, President and Chief Executive Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:leonard-s-schleifer-m-d-ph-d-regeneron-pharmaceuticals-inc","name":"Leonard S. Schleifer, M.D., Ph.D."},"title":"Board co-Chair, President and Chief Executive Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:document:bfaa15f5ba82da1d14fb28148e414ec5206e186b9707d93429af346776541043","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001308179-26-000340","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":"2026-04-24T00:00:00+00:00","retrieved_at":"2026-09-14T16:52:57.731588+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_record:28","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Audit: Chair George L. Sing; Members George L. Sing (Chair); Anita J. Ryan","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Audit","canonical_type":"audit","chair":"George L. Sing","members":[{"display_name":"George L. Sing","person_slug":"george-l-sing","is_chair":true},{"display_name":"Anita J. Ryan","person_slug":"arthur-f-ryan","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:158ef090c3ad2807947a27e846a1bcfe83a16821367e4fc9ca00a2e35137f4b8","identity_scope":"representation_reference","source_type":"sp500-board-director-completeness-remediation-2026-05-15","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_appointment:29","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:george-l-sing","object_label":"George L. Sing","object_source_name_forms":[],"value":"George L. Sing: chair, Audit","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:george-l-sing","name":"George L. Sing"},"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:158ef090c3ad2807947a27e846a1bcfe83a16821367e4fc9ca00a2e35137f4b8","identity_scope":"representation_reference","source_type":"sp500-board-director-completeness-remediation-2026-05-15","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_appointment:30","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:arthur-f-ryan","object_label":"Anita J. Ryan","object_source_name_forms":[],"value":"Anita J. Ryan: member, Audit","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:arthur-f-ryan","name":"Anita J. Ryan"},"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:158ef090c3ad2807947a27e846a1bcfe83a16821367e4fc9ca00a2e35137f4b8","identity_scope":"representation_reference","source_type":"sp500-board-director-completeness-remediation-2026-05-15","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_record:31","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Compensation: Chair Christine A. Poon; Members Christine A. Poon (Chair); George L. Sing","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Compensation","canonical_type":"compensation","chair":"Christine A. Poon","members":[{"display_name":"Christine A. Poon","person_slug":"christine-a-poon","is_chair":true},{"display_name":"George L. Sing","person_slug":"george-l-sing","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:158ef090c3ad2807947a27e846a1bcfe83a16821367e4fc9ca00a2e35137f4b8","identity_scope":"representation_reference","source_type":"sp500-board-director-completeness-remediation-2026-05-15","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_appointment:32","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:christine-a-poon","object_label":"Christine A. Poon","object_source_name_forms":[],"value":"Christine A. Poon: chair, Compensation","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:christine-a-poon","name":"Christine A. Poon"},"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:158ef090c3ad2807947a27e846a1bcfe83a16821367e4fc9ca00a2e35137f4b8","identity_scope":"representation_reference","source_type":"sp500-board-director-completeness-remediation-2026-05-15","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_appointment:33","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:george-l-sing","object_label":"George L. Sing","object_source_name_forms":[],"value":"George L. Sing: member, Compensation","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:george-l-sing","name":"George L. Sing"},"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:158ef090c3ad2807947a27e846a1bcfe83a16821367e4fc9ca00a2e35137f4b8","identity_scope":"representation_reference","source_type":"sp500-board-director-completeness-remediation-2026-05-15","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_record:34","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Corporate Governance and Compliance: Chair Anita J. Ryan; Members Anita J. Ryan (Chair); Christine A. Poon; Craig B. Thompson","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Corporate Governance and Compliance","canonical_type":"nominating_governance","chair":"Anita J. Ryan","members":[{"display_name":"Anita J. Ryan","person_slug":"arthur-f-ryan","is_chair":true},{"display_name":"Christine A. Poon","person_slug":"christine-a-poon","is_chair":false},{"display_name":"Craig B. Thompson","person_slug":"craig-b-thompson","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:158ef090c3ad2807947a27e846a1bcfe83a16821367e4fc9ca00a2e35137f4b8","identity_scope":"representation_reference","source_type":"sp500-board-director-completeness-remediation-2026-05-15","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_appointment:35","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:arthur-f-ryan","object_label":"Anita J. Ryan","object_source_name_forms":[],"value":"Anita J. Ryan: chair, Corporate Governance and Compliance","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"Corporate Governance and Compliance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:arthur-f-ryan","name":"Anita J. Ryan"},"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:158ef090c3ad2807947a27e846a1bcfe83a16821367e4fc9ca00a2e35137f4b8","identity_scope":"representation_reference","source_type":"sp500-board-director-completeness-remediation-2026-05-15","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_appointment:36","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:christine-a-poon","object_label":"Christine A. Poon","object_source_name_forms":[],"value":"Christine A. Poon: member, Corporate Governance and Compliance","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"Corporate Governance and Compliance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:christine-a-poon","name":"Christine A. Poon"},"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:158ef090c3ad2807947a27e846a1bcfe83a16821367e4fc9ca00a2e35137f4b8","identity_scope":"representation_reference","source_type":"sp500-board-director-completeness-remediation-2026-05-15","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_appointment:37","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:craig-b-thompson","object_label":"Craig B. Thompson","object_source_name_forms":[],"value":"Craig B. Thompson: member, Corporate Governance and Compliance","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"Corporate Governance and Compliance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:craig-b-thompson","name":"Craig B. Thompson"},"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:158ef090c3ad2807947a27e846a1bcfe83a16821367e4fc9ca00a2e35137f4b8","identity_scope":"representation_reference","source_type":"sp500-board-director-completeness-remediation-2026-05-15","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_record:38","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Digital Technology: Chair not stated; Members Craig B. Thompson","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Digital Technology","canonical_type":"technology","chair":null,"members":[{"display_name":"Craig B. Thompson","person_slug":"craig-b-thompson","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:158ef090c3ad2807947a27e846a1bcfe83a16821367e4fc9ca00a2e35137f4b8","identity_scope":"representation_reference","source_type":"sp500-board-director-completeness-remediation-2026-05-15","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_appointment:39","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:craig-b-thompson","object_label":"Craig B. Thompson","object_source_name_forms":[],"value":"Craig B. Thompson: member, Digital Technology","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"Digital Technology","category":"technology","role":"member","person":{"alpha_id":"alpha:person:craig-b-thompson","name":"Craig B. Thompson"},"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:158ef090c3ad2807947a27e846a1bcfe83a16821367e4fc9ca00a2e35137f4b8","identity_scope":"representation_reference","source_type":"sp500-board-director-completeness-remediation-2026-05-15","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_record:40","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Technology: Chair not stated; Members Craig B. Thompson","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Technology","canonical_type":"technology","chair":null,"members":[{"display_name":"Craig B. Thompson","person_slug":"craig-b-thompson","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:158ef090c3ad2807947a27e846a1bcfe83a16821367e4fc9ca00a2e35137f4b8","identity_scope":"representation_reference","source_type":"sp500-board-director-completeness-remediation-2026-05-15","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_appointment:41","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:craig-b-thompson","object_label":"Craig B. Thompson","object_source_name_forms":[],"value":"Craig B. Thompson: member, Technology","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"Technology","category":"technology","role":"member","person":{"alpha_id":"alpha:person:craig-b-thompson","name":"Craig B. Thompson"},"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:158ef090c3ad2807947a27e846a1bcfe83a16821367e4fc9ca00a2e35137f4b8","identity_scope":"representation_reference","source_type":"sp500-board-director-completeness-remediation-2026-05-15","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:index_membership:42","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasIndexMembership","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"S&P 500 (SPX)","claim_type":"index_membership","predicate_id":"alpha:predicate:index_membership","predicate_version":1,"machine_key":"index_membership","human_label":"Index Membership","governed_predicate":true,"machine_value":"S&P 500 (SPX)","corroboration_count":1,"source_claim_count":1,"valid_from":"2013-05-01","valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:827a22a1567eda11fa866650563f33918ee2975144378fa7fd6f46399da5427a","identity_scope":"representation_reference","source_type":"index_provider","title":"S&P 500","publisher":"Slickcharts S&P 500 constituent table (public observation, not S&P DJI license)","url":"https://www.slickcharts.com/sp500","source_date":null,"retrieved_at":"2026-09-02T01:46:54.035948+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":"2013-05-01","effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:index_membership:43","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasIndexMembership","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Nasdaq-100 (NDX)","claim_type":"index_membership","predicate_id":"alpha:predicate:index_membership","predicate_version":1,"machine_key":"index_membership","human_label":"Index Membership","governed_predicate":true,"machine_value":"Nasdaq-100 (NDX)","corroboration_count":1,"source_claim_count":1,"valid_from":"2026-09-01","valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:24e3e0a1948ea10a66303a2e7032cc9bbc5c4edf5c6d4eb77b262a15ea2009a5","identity_scope":"representation_reference","source_type":"index_provider","title":"Nasdaq-100","publisher":"Nasdaq official Nasdaq-100 list-type API","url":"https://api.nasdaq.com/api/quote/list-type/nasdaq100","source_date":null,"retrieved_at":"2026-09-02T01:47:46.199772+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":"2026-09-01","effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:security_listing:44","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasSecurityListing","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"REGN (NASDAQ)","claim_type":"security_listing","predicate_id":"alpha:predicate:security_listing","predicate_version":1,"machine_key":"security_listing","human_label":"Security Listing","governed_predicate":true,"machine_value":{"kind":"security_listing","ticker":"REGN","exchange":"NASDAQ","exchange_display":"NASDAQ","mic":"XNAS","currency":"Unavailable","security_type":"equity","listing_status":"active","is_primary":true},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:bb1a4a424fa8202edd898231e1b29c0b0f9d1451c1dd90f65aab19d9158e4505","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/regeneron-pharmaceuticals-inc","source_date":null,"retrieved_at":"2026-10-17T04:45:14.05764+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:bb1a4a424fa8202edd898231e1b29c0b0f9d1451c1dd90f65aab19d9158e4505","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/regeneron-pharmaceuticals-inc","source_date":null,"retrieved_at":"2026-10-17T04:45:14.05764+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:d5f9d8672c40ba80285d68faa0577c9aa742ef81c5842dd994b43587f2f9fabf","identity_scope":"representation_reference","source_type":"SEC filing","title":"REGENERON PHARMACEUTICALS, INC. Form 10-K (filed 2026-02-04)","publisher":"REGENERON PHARMACEUTICALS, INC. Form 10-K (filed 2026-02-04)","url":"https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/regn-20251231.htm","source_date":null,"retrieved_at":"2026-08-29T22:22:03Z","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Regeneron Pharmaceuticals, Inc. DEF 14A 2026-04-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":"2026-04-24","retrieved_at":"2026-04-24T20:10:05.384+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:bfaa15f5ba82da1d14fb28148e414ec5206e186b9707d93429af346776541043","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001308179-26-000340","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":"2026-04-24T00:00:00+00:00","retrieved_at":"2026-09-14T16:52:57.731588+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:d1265880b1e2ef08d82c9a445c87fe66862069e264638236b86548dd48aa0a99","identity_scope":"source_document_reference","source_type":"sec_filing","title":"REGN 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/regn-20251231.htm","source_date":"2026-02-04T00:00:00+00:00","retrieved_at":"2026-07-11T00:40:32.155611+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:158ef090c3ad2807947a27e846a1bcfe83a16821367e4fc9ca00a2e35137f4b8","identity_scope":"representation_reference","source_type":"sp500-board-director-completeness-remediation-2026-05-15","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:827a22a1567eda11fa866650563f33918ee2975144378fa7fd6f46399da5427a","identity_scope":"representation_reference","source_type":"index_provider","title":"S&P 500","publisher":"Slickcharts S&P 500 constituent table (public observation, not S&P DJI license)","url":"https://www.slickcharts.com/sp500","source_date":null,"retrieved_at":"2026-09-02T01:46:54.035948+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:24e3e0a1948ea10a66303a2e7032cc9bbc5c4edf5c6d4eb77b262a15ea2009a5","identity_scope":"representation_reference","source_type":"index_provider","title":"Nasdaq-100","publisher":"Nasdaq official Nasdaq-100 list-type API","url":"https://api.nasdaq.com/api/quote/list-type/nasdaq100","source_date":null,"retrieved_at":"2026-09-02T01:47:46.199772+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.834,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.879,"cross_source_agreement":0.75,"temporal_completeness":0.533},"diagnostics":{"published_claims":43,"factual_claims":43,"claims_with_linked_evidence":43,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":30,"temporal_claims_with_valid_from":16,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-17T04:45:14.05764+00:00","observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":"2026-10-17T04:45:14.05764+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":43,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/regeneron-pharmaceuticals-inc/evidence","section":"evidence","href":"https://registry.alpha.ac/api/public/companies/regeneron-pharmaceuticals-inc?format=record&section=evidence","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}